Table 4.
Postoperative early complications of our study population.
| Characteristics | ERAS group (n=305) | Routine group (n=306) | P value |
|---|---|---|---|
| PPCs a (%) | 35 (11.5%) | 70 (22.9%) | <0.001 |
| Pneumonia | 17 (5.6%) | 27 (8.8%) | 0.163 |
| Atelectasis | 13 (4.3%) | 25 (8.2%) | 0.046 |
| Air leak (≥5 days) | 6 (2.0%) | 22 (7.2%) | 0.003 |
| Bronchopleural fistula |
1 (0.3%) | 1 (0.3%) | 1.000 |
| Respiratory failure | 2 (0.7%) | 3 (1.0%) | 1.000 |
| Supraventricular arrhythmia (%) | 7 (2.3%) | 12 (3.9%) | 0.348 |
| Acute myocardial infarction (%) |
0 (0%) | 1 (0.3%) | 1.000 |
| Acute cerebral stroke (%) | 1 (0.3%) | 2 (0.7%) | 1.000 |
| VTEb (%) | 0 (0%) | 2 (0.7%) | 0.497 |
| Urinary irritation (%) | 19 (6.2%) | 78 (25.5%) | <0.001 |
| Acute urinary retention (%) | 2 (0.7%) | 5 (1.6%) | 0.449 |
aPPCs, pulmonary complications. Four patients in ERAS group had ≥ 2 PPCs, eight patient in Routine group had ≥ 2 PPCs.
bvenous thromboembolism, including deep venous thrombosis (DVT) and pulmonary thromboembolism (PTE).